Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTA Recommended Approach For Treating Canine OAManaging pain from canine OA doesn’t have to be complicated. Discover an approach that doesn’t just treat pain, but addresses inflammation, too. + Learn More